AU2001242823A1 - Selective preventives/remedies for progressive lesions after organ damage - Google Patents

Selective preventives/remedies for progressive lesions after organ damage

Info

Publication number
AU2001242823A1
AU2001242823A1 AU2001242823A AU4282301A AU2001242823A1 AU 2001242823 A1 AU2001242823 A1 AU 2001242823A1 AU 2001242823 A AU2001242823 A AU 2001242823A AU 4282301 A AU4282301 A AU 4282301A AU 2001242823 A1 AU2001242823 A1 AU 2001242823A1
Authority
AU
Australia
Prior art keywords
preventives
remedies
selective
organ damage
progressive lesions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001242823A
Inventor
Michio Ishibashi
Charles Mioskowski
Catherine Sylvain
Alain Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001242823A1 publication Critical patent/AU2001242823A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
AU2001242823A 2000-03-28 2001-03-27 Selective preventives/remedies for progressive lesions after organ damage Abandoned AU2001242823A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000088990 2000-03-28
JP2000-88990 2000-03-28
JP2000289458 2000-09-22
JP2000-289458 2000-09-22
PCT/JP2001/002513 WO2001072730A1 (en) 2000-03-28 2001-03-27 Selective preventives/remedies for progressive lesions after organ damage

Publications (1)

Publication Number Publication Date
AU2001242823A1 true AU2001242823A1 (en) 2001-10-08

Family

ID=26588576

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001242823A Abandoned AU2001242823A1 (en) 2000-03-28 2001-03-27 Selective preventives/remedies for progressive lesions after organ damage

Country Status (4)

Country Link
US (2) US6878745B2 (en)
EP (1) EP1277747A4 (en)
AU (1) AU2001242823A1 (en)
WO (1) WO2001072730A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541174A4 (en) * 2002-09-11 2005-09-14 Michio Ishibashi Drug or cosmetic
JPWO2007142309A1 (en) * 2006-06-09 2009-10-29 道男 石橋 Screening method for renal glomerular therapeutic agent
JPWO2008133036A1 (en) * 2007-04-12 2010-07-22 道男 石橋 Screening method for therapeutic agent for renal tubular disorder
JP2012171907A (en) * 2011-02-21 2012-09-10 Nara Medical Univ Medicine for repairing, regenerating and treating internal organ tissue by novel benzoisofranone derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62228075A (en) * 1985-04-30 1987-10-06 Takeda Chem Ind Ltd Antimicrobial compound, production and use thereof
JP3122161B2 (en) * 1991-05-16 2001-01-09 武田薬品工業株式会社 γ-lactone immunosuppressant
US5550132A (en) * 1994-06-22 1996-08-27 University Of North Carolina Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
WO1996005302A1 (en) * 1994-08-11 1996-02-22 Takeda Chemical Industries, Ltd. G protein coupled receptor protein, production, and use thereof
US6165785A (en) * 1996-05-24 2000-12-26 University Of Cincinnati Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications

Also Published As

Publication number Publication date
US20050143453A1 (en) 2005-06-30
US6878745B2 (en) 2005-04-12
US20030181506A1 (en) 2003-09-25
WO2001072730A1 (en) 2001-10-04
EP1277747A4 (en) 2009-07-29
EP1277747A1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001286221A1 (en) Remedies for ischemic diseases
AU2001244487A1 (en) An insertion device for an endoscope
AU8622101A (en) Remedies for ischemic diseases
AU2002215116A1 (en) Expander
AU2001283989A1 (en) Surface-active photoinitiators
AU2001290685A1 (en) Methods for inhibiting inflammatory disease
AU2001252599A1 (en) Remedies for cancer
AU2002224919A1 (en) Surface-active photoinitiators
AU2001259702A1 (en) Tissue regrafting
EP1151667A3 (en) Plant-activating agent
AU2002231669A1 (en) Surface-active photoinitiators
AU2001277711A1 (en) Remedies for cisplatin-tolerant cancer
AU2002210925A1 (en) Preventives/remedies for portal hypertension
HK1069770A1 (en) Remedies for dermatophytosis
PT1344526E (en) Preventives/remedies for inflammatory airway diseases
AU2002224596A1 (en) Preventives or remedies for obesity or fatty liver
AU3987800A (en) Preventives/remedies for angiostenosis
AU2001232271A1 (en) Preventives/remedies for postoperative stress
AU2371201A (en) Endoscope
AU2001242823A1 (en) Selective preventives/remedies for progressive lesions after organ damage
AU2002222676A1 (en) Preventives or remedies for endometriosis
AU2001269335A1 (en) Multiple expander
AU2001269336A1 (en) Multiple expander